|
|
Research
Highlights
Grants
/ Funding
Wearden
ME. Toxicology of inhaled nitric oxide; The Methodist Foundation,
$45,000
Weisman
LE. Novel therapies for neonates; Abbott Laboratories Inc.,
$100,000
Publications
Garcia-Prats
JA, Cooper TR. The critically ill neonate with infection:
Management considera-tions in the term and preterm infant. Seminars
in Pediatric Infectious Diseases Jan. 2000; 11(1): 4-12.
Moorthy
B, Parker K, Smith CV, Bend JR, Welty S. Potentiation
of oxygen-induced lung injury in rats by the mechanism-based cytochrome
P-450 inhibitor, 1-aminobenzotriazole. J Phar-macol Exp Ther 2000;
292:553-560.
Nemeth
BA, Tsang SW, Geske RS, Haney PM. Golgi targeting of the
GLUT1 glucose transporter in lactating mouse mammary gland. Pediatr
Res 2000; 47:444-450.
Speer
ME. American Academy of Pediatrics. Committee on Fetus and
Newborn (member). Prevention and management of pain and stress
in the neonate. Pediatrics 2000; 105:454-461.
O’Donovan
D, Wearden M, Adams J. Unilateral pulmonary interstitial emphysema
following pneumonia in a preterm infant successfully treated with
prolonged selective bronchial intubation. Am J Perinatol 1999;
16:327-331.
Richard
J. Schanler, MD, Guest Editor, Symposium: Bioactivity in milk
and bacterial interactions in the developing immature intestine
for Journal of Nutrition, Vol. 130, Feb. 2000.
Events
Michael
E Speer, MD, installed as President of the Harris County Medical
Society.
Leonard
E. Weisman, MD, appointed Member, National Institutes of Child
Health and Human Development, Neonatal Pharmacology Network.
|
